NiO-YSZ based cermets are the most widely adopted materials for SOFC anodes. Citrate-nitrate combustion synthesis was used for the preparation of NiO-YSZ. The main advantage of the preparation method used was reflected in the fact that after the synthesis both phases NiO and YSZ were randomly distributed on a nanometer level. The prepared NiO-YSZ powder composites were shaped, sintered at different temperatures and reduced to Ni-YSZ and subsequently submitted to microstructure investigations.
COBISS.SI-ID: 34080773
In this work a solution of a difficult problem of polymorphism of lithium manganese silicate is reported. The material is potentially applicable as cathode material in rechargeable lithium batteries. Different synthesis and working conditions result in various polymorphjic forms, which can cause some changes in the properties of the cathode. Combination of various methods lead to clarification of plymorph transitions and and definition of conditions leading to defined polymorphic forms. Our group contributed essentially with the results on structural studies, based on powder diffraction.
COBISS.SI-ID: 4386074
Nickel(II) complexes with the quinolone antibacterial agent flumequine in the presence of nitrogen donor heterocyclic ligands were synthesized and structurally characterized. The crystal structures of the first flumequinato complexes were reported: bis(4-benzylpyridine)bis(flumequinato)nickel, (2,2'-bipyridine)bis(flumequinato)nickel and (1,10-phenanthroline)bis(flumequinato)nickel. Competitive study with ethidium bromide, the cyclic voltammograms and UV study have shown that the complexes bind strongly to CT DNA and to serum albumin protein.
COBISS.SI-ID: 34055941
Complexes of metal chlorides are useful starting compounds for syntheses of coordination and organometalic compounds. We report the syntheses and structures of five novel manganese, nickel and zinc chloride complexes.
COBISS.SI-ID: 34687493
Partially. In colaboration with the pharmaceutical company Krka d.d. we have investigated the cocrystalization of fluconazole: a wide spectrum triazole antifungal agent used in the treatment of localized candidiasis and systematic therapy of candidial infections, dermatophytic fungal infections and cryptococcal meningitis. It is commonly used as accompanying therapy for immunodeficient patients with AIDS or cancer and patients taking immunodepresive agents. It is only slightly soluble in water. Along these lines we have focused our research to the preparation of new fluconazole cocrystals.
COBISS.SI-ID: 2881905